Fuse Oncology Scales Radiation Workflow Platform Beyond Physicians

The expansion builds on the company’s existing physician-facing solution, now incorporating the BluePrint application. Originally developed at the University of Michigan, BluePrint standardizes treatment planning from initial intent through final approval. By housing these disparate roles within a single environment, Fuse aims to eliminate the redundant manual entries that currently stall clinical progress.

This integrated approach draws from real-world performance at Cone Health, a Risant Health facility. Prototype testing at the site demonstrated a significant reduction in wait times, bringing the interval from consultation to treatment down to 3.4 days. Beyond efficiency, the model achieved high marks in staff engagement and patient satisfaction scores. Fuse Oncology will showcase these role-specific workflows at the upcoming ASTRO 2026 Annual Meeting in Boston.